首页> 外文期刊>Natural Products and Bioprospecting >Utilization of Swertia chirayita Plant Extracts for Management of Diabetes and Associated Disorders: Present Status, Future Prospects and Limitations
【24h】

Utilization of Swertia chirayita Plant Extracts for Management of Diabetes and Associated Disorders: Present Status, Future Prospects and Limitations

机译:利用<斜视> shiria chirayita 植物提取物用于糖尿病和相关疾病的管理:现状,未来前景和限制

获取原文
           

摘要

Diabetes mellitus is referred as common metabolic abnormalities characterized as hyperglycemia, mainly caused due to insufficient production of insulin at cellular level or/and defects in insulin action. Such an endocrine disorder is responsible for serious health problems and its worldwide prevalence is rapidly increasing. Common management of diabetes by oral administration of drugs without creating any side effects is still considered a challenging task and increasing cost of conventional medicine in developing countries is another matter of concern. To address these issues, traditional preparations of herbal plant extracts in the form of medicines already gained immense attention. Swertia chirayita is one among such plants which is known for its hypoglycemic potential. Numerous chemical constituents with promising pharmacological properties have been identified from such plant extracts but still, such compounds have not been well characterized, specifically against human application. Hence, more research efforts are necessitated to understand exact mechanism of such compounds and to develop overall safety of such plant formulations. Present review clearly represents antidiabetic properties of Swertia chirayita extract , strategies to be taken to strengthen its safety application on humans and biotechnological interventions that ensure conservation of such endangered species to promote its future application in modern medicine. Graphic Abstract
机译:糖尿病被称为常见的代谢异常,其特征为高血糖,主要是由于胰岛素水平或/和胰岛素作用缺陷产生的胰岛素的不足导致。这种内分泌疾病对严重的健康问题负责,其全世界普遍性迅速增加。口服药物糖尿病患者的常见管理仍然被认为是一个具有挑战性的任务,发展中国家常规医学的成本增加是另一个关注的问题。为了解决这些问题,以药物形式的草药植物提取物的传统制剂已经获得了巨大的关注。 Shertia chirayita是这种植物中的一种,其植物是其低血糖潜力的。已经从这种植物提取物中鉴定出具有有前途的药理学性质的许多化学成分,但仍然存在这种化合物,特别是对人类应用的特异性。因此,需要更多的研究努力来了解这些化合物的确切机制,并制定这种植物制剂的整体安全性。目前的审查明确代表了Swertia Chirayita提取物的抗糖尿病性质,加强其对人类安全应用和生物技术干预措施的策略,确保保护这种濒危物种,以促进现代医学的未来申请。图形摘要

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号